Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Ansichten
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Zeig mehr
Facebook Kommentare
Keine Kommentare gefunden